FAP and large cell neuroendocrine carcinoma: NSCLC can express FAP in up to 100% of cases, whereas small-cell lung cancer (SCLC) and large-cell neuroendocrine carcinoma (LCNC) exhibit FAP expression in up to 67% of cases [59].